Aurinia (Formerly Known as Isotechnika Pharma Inc.)
5120 - 75th Street
Edmonton
Alberta
T6E 6W2
Canada
Tel: 780-487-1600
Fax: 780-484-4105
Website: http://www.auriniapharma.com/
287 articles about Aurinia (Formerly Known as Isotechnika Pharma Inc.)
-
Isotechnika Inc. Announces Interim Three Month Data from Phase 2b Kidney Transplant Trial
5/7/2007
-
Isotechnika Inc.'s partner, Lux Biosciences, Receives No Objection Letter from Health Canada for ISA247 Phase 2/3 Clinical Trials for Uveitis
5/2/2007
-
Isotechnika Inc.'s Partner, Lux Biosciences, Initiates LUMINATE Pivotal Trials In Uveitis For ISA247
2/20/2007
-
Isotechnika Inc. Invited To Participate In Panel At RBC Capital Markets Health Care Conference
12/12/2006
-
Isotechnika Inc. Enrolls First Patient In European/Canadian Phase III Psoriasis Clinical Trial
12/5/2006
-
Isotechnika Inc.'s Lead Immunosuppressive Drug, ISA247 Positioned To Enter Phase II/III Clinical Trials For Uveitis By Its Partner Lux Biosciences
11/28/2006
-
Isotechnika Inc. Receives Notice Of Allowance For mTOR Inhibitor, TAFA93
11/21/2006
-
Isotechnika Inc. Announces Initial Data From Phase IIb Kidney Transplant Trial
11/16/2006
-
Isotechnika Inc. To Announce Initial Data From Phase IIb Kidney Transplant Trial
11/14/2006
-
Isotechnika Inc. Announces Highlights And Financial Results For Third Quarter Of 2006
11/14/2006
-
Isotechnika Inc. Reports Final Safety And Efficacy Data From Phase III Psoriasis Extension Trial
10/5/2006
-
Isotechnika Inc. To Update Investment Community At BioContact Québec
10/4/2006
-
Isotechnika Inc. Receives No Objection Letter From Health Canada For Second Phase III Psoriasis Clinical Trial
10/4/2006
-
Isotechnika Inc. Receives European Patent For Lead Immunosuppressive Drug, ISA247
10/3/2006
-
Isotechnika Inc. Receives Approval From The German Competent Authority For A Pivotal Phase III Psoriasis Clinical Trial
10/2/2006
-
Isotechnika Inc. Announces Promising Results From Phase I TAFA93 Trials
8/21/2006
-
Isotechnika Inc. Announces Cancellation Of Equity Line Drawdown
8/15/2006
-
Isotechnika Inc. Announces Highlights And Financial Results For Second Quarter Of 2006
8/3/2006
-
Isotechnika Inc. Issues Drawdown Notice Under Equity Drawdown Facility
7/14/2006
-
Isotechnika Inc. Will Be Represented At The Canadian Dermatology Annual Conference
6/30/2006